RE: Deja vu?25 May 2022 11:28
As I see it, the SPA sum of £14,052,000 for fully purchasing their 49% stake relies on ANGS being able to fulfil the entire cash raise with Aleph. Part of this consists of the 2nd tranche of shares that definitely require shareholder approval.
I personally don't believe ANGS had to take this 100% purchase at this time as it raises too many concerns/disruptions etc. It represents an unacceptable risk of taking on 100% of the hedge at a time when flow rates and sidetrack results are thus far unknown.
So, I have every intention of declining approval. ANGS is better served short-term in maintaining its current position. Instead, GL and the BOD have taken an unnecessary risk and devestated the SP with unnecessary dilution.
I'm not happy with their decisions nor a MINIMUM 2 week slip... so much for any hope of GL redeeming himself.
P.S. I find it HIGHLY irregular that GPS, a major shareholder, should somehow know to sell up just prior to a major dilution event. Sounds utterly back-handed to me and I intend to vote against the additional 2nd tranche.
You can all make your own decisions, but GL deserves a smack in the face!!!